Active — Not RecruitingNot Applicable

The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies

Taiwan30 participantsStarted 2023-01-01

Plain-language summary

pediatric migraine

Age range6 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Receiving antibiotic treatment for the past 2 weeks
✕. Receiving probiotic treatment for the past one month
✕. Multiple congenital anomalies, for instance, meningoencephalocele, chromosomal anomalies, and congenital intestinal atresia, etc.
✕. Mental retardation that is difficult to describe the symptoms

The efficacy of beneficial intestinal microbiota in the treatment of migraine and its mechanism: basic and clinical studies

Timeframe: From enrollment to the end of treatment at 12 weeks

NCT IDNCT07092241

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-20